Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-17-006275
Filing Date
2017-08-08
Accepted
2017-08-08 16:08:13
Documents
68
Period of Report
2017-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q nviv-20170630x10q.htm 10-Q 1142195
2 EX-10.1 nviv-20170630ex101da601c.htm EX-10.1 182058
3 EX-31.1 nviv-20170630ex311fb1736.htm EX-31.1 15136
4 EX-31.2 nviv-20170630ex312b874ac.htm EX-31.2 15148
5 EX-32.1 nviv-20170630ex32150aec7.htm EX-32.1 8175
6 EX-32.2 nviv-20170630ex322f5d5e6.htm EX-32.2 8191
  Complete submission text file 0001558370-17-006275.txt   5067839

Data Files

Seq Description Document Type Size
7 EX-101.INS nviv-20170630.xml EX-101.INS 952161
8 EX-101.SCH nviv-20170630.xsd EX-101.SCH 37272
9 EX-101.CAL nviv-20170630_cal.xml EX-101.CAL 37870
10 EX-101.DEF nviv-20170630_def.xml EX-101.DEF 154190
11 EX-101.LAB nviv-20170630_lab.xml EX-101.LAB 374409
12 EX-101.PRE nviv-20170630_pre.xml EX-101.PRE 286886
Mailing Address ONE KENDALL SQUARE BUILDING 1400 EAST 4TH FLOOR CAMBRIDGE MA 02139
Business Address ONE KENDALL SQUARE BUILDING 1400 EAST 4TH FLOOR CAMBRIDGE MA 02139 617-863-5524
INVIVO THERAPEUTICS HOLDINGS CORP. (Filer) CIK: 0001292519 (see all company filings)

EIN.: 000000000 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37350 | Film No.: 171014780
SIC: 3841 Surgical & Medical Instruments & Apparatus